Wajih Zaheer MD, FACP

Asstt Clinical Professor Of Medicine (Medical Oncology)

Clinical Interests

solid tumor malignancies, particularly breast, lung, and gastrointestinal cancers/pancreatic cancer ; hematologic malignancies such as lymphoma, leukemia, and myeloproliferative disorders. Genitourinary malignancies.


Board Certifications

1996
Hematology, Internal Medicine, Board Certified
1991
Internal Medicine, Board Certified
1995
Medical Oncology, Board Certified

Patient Care Locations

 
wajih_zaheerfaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Colorectal Cancer and Colon A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer (CALGB 80702)
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Cancer, Breast - Female, and Breast - Male Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer (S1207)
Breast - Female and Breast - Male A Randomized, Multicenter, Open-label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast Cancer who have Residual Tumor Present Pathologically in the Breast or Axillary Lymph Nodes following Preoperative Therapy (NSABP B50/Katherine Study)
Pancreas Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer

More Clinical Trials...

Edit Profile